Sfoglia per Rivista
Dendritic cell recovery after allogeneic stem cell transplantation.
2002-01-01 Stocchi, R.; Damiani, Daniela; Masolini, P.; Michelutti, A.; Geromin, A.; Sperotto, A.; Skert, C.; Tomadini, V.; Cerno, M.; Baccarani, M.; Fanin, R.
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection
2004-01-01 Libra, M; DE RE, V; Gloghini, A; Gasparotto, D; Gragnani, L; Navolanic, Pm; DE VITA, Salvatore; Mazzarino, Mc; Zignego, Al; Carbone, A; Boiocchi, M.
Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons.
1994-01-01 Silvestri, F; Virgolini, L; Mazzolini, A; Bertolissi, F; Russo, D; Fanin, Renato; Baccarani, M.
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
2002-01-01 Patriarca, Francesca; Sperotto, A; Filì, C; Zaja, Francesco; Prosdocimo, S; Fanin, Renato
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells.
1997-01-01 Michelutti, A; Michieli, M; Damiani, Daniela; Melli, C; Ermacora, A; Grimaz, S; Candoni, A; Russo, D; Fanin, Renato; Baccarani, M.
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.
2006-01-01 Patriarca, Francesca; Skert, C; Bonifazi, F; Sperotto, A; Fili, C; Stanzani, M; Zaja, Francesco; Cerno, M; Geromin, A; Bandini, G; Baccarani, M; Fanin, Renato
Efficacy and toxycity of Fludarabin, Ara-C and Idarubicin vs Idarubucin, ARA-C and Etoposide for induction treatment of newly diagnosed acute myeloid leukemia patients, younger than 60 years.
2003-01-01 Russo, D.; Martinelli, G.; Damiani, Daniela; Malagola, M.; Isidori, A.; De Vivo, A.; Visani, G.; Candoni, A.; Michelutti, A.; Fanin, R.; Piccaluga, P.; Bonini, A.; Avanzini, P.; Gugliottta, L.; Zuffa, E.; Zaccaria, A.; Raspadori, D.; Bocchia, M.; Lauria, F.; Pricolo, G.; Mazza, P.; Pierri, I.; Gobbi, M.; Baccarani, M.
Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
2005-01-01 Patriarca, Francesca; Prosdocimo, S; Tomadini, V; Vasciaveo, A; Bruno, B; Fanin, Renato
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
2021-01-01 Gentile, M.; Specchia, G.; Derudas, D.; Galli, M.; Botta, C.; Rocco, S.; Conticello, C.; Califano, C.; Giuliani, N.; Mangiacavalli, S.; Attingenti, E.; Lombardo, A.; Brunori, M.; Rossi, E.; Antonioli, E.; Ria, R.; Zambello, R.; Di Renzo, N.; Mele, G.; Marcacci, G.; Musto, P.; Capalbo, S.; Cascavilla, N.; Cerchione, C.; Belotti, A.; Criscuolo, C.; Uccello, G.; Curci, P.; Vigna, E.; Fraticelli, V.; Vincelli, D.; Bonalumi, A.; Siniscalchi, A.; Stocchi, R.; Martino, M.; Ballanti, S.; Gangemi, D.; Gagliardi, A.; Gamberi, B.; Pompa, A.; Recchia, A. G.; Tripepi, G.; Pitino, A.
“Expression of Multidrug resistance gene (MDR-1) in human normal leukocytes”
1993-01-01 Damiani, Daniela; Michieli, M.; Michelutti, A.; Geromin, A.; Raspadori, D.; Fanin, Renato; Savignano, C.; Giacca, M.; Pileri, S.; Mallardi, F.; Baccarani, M.
Factor V leiden increases plasma F1+2 levels both in normal and deep venous thrombosis subjects.
2000-01-01 Mercuri, F; Giacomello, Roberta; Puglisi, Fabio; Colaone, R; Fabbro, D; Menegon, Mg; Ceriello, A; Gonano, Fabio; Damante, Giuseppe
FEASIBILITY AND OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH POOR RISK ACUTE MYELOID LEUKEMIA
2009-01-01 Candoni, A.; Simeone, E.; Sperotto, A.; Geromin, A.; Cerno, M.; Patriarca, Francesca; Zaja, Francesco; Damiani, Daniela; Fanin, R.
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS
2002-01-01 Damiani, Daniela; Stocchi, R; Masolini, M; Sperotto, A; Geromin, A; Skert, C; Cerno, M; Baccarani, M; Fanin, Renato
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: A pooled analysis of two randomized trials
2020-01-01 Larocca, A.; Mina, R.; Offidani, M.; Liberati, A. M.; Ledda, A.; Patriarca, F.; Evangelista, A.; Spada, S.; Benevolo, G.; Oddolo, D.; Innao, V.; Cangiolosi, C.; Bernardini, A.; Musto, P.; Amico, V.; Fraticelli, V.; Paris, L.; Giuliani, N.; Falcone, A. P.; Zambello, R.; de Paoli, L.; Romano, A.; Palumbo, A.; Montefusco, V.; Hajek, R.; Boccadoro, M.; Bringhen, S.
FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) AS INDUCTION CHEMOTHERAPY OF ADULT ACUTE MYELOID LEUKEMIA. A PILOT STUDY REPORT
2009-01-01 A., Candoni; E., Simeone; A., Michelutti; Damiani, Daniela; D., Russo; R., Fanin
FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) INDUCTION CHEMOTHERAPY FOR ADULT ACUTE MYELOID LEUKEMIA. RESULTS OF A PILOT STUDY
2009-01-01 Candoni, A.; Tiribelli, Mario; Simeone, E.; Volpetti, S.; Florio, F.; Malagola, M.; Damiani, Daniela; Russo, D.; Fanin, R.
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
2003-01-01 Mauro, Fr; Zinzani, P; Zaja, Francesco; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, Renato; Baccarani, M; Tura, S; Mandelli, F.
Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia.
1998-01-01 Russo, D; Candoni, A; Grattoni, R; Bertone, A; Zaja, Francesco
Fludarabine, Arabynosil cytosine and Idarubicin (FLAI), a combination of non MDR related drugs for tratment of patients with newly diagnosed acute myeloi leukemia.
2003-01-01 Russo, D.; Damiani, Daniela; Martinelli, G.; Candoni, A.; Pricoli, G.; Pierri, I.; Zuffa, E.; Raspadori, D.; Bocchia, M.; Michelutti, A.; De Vivo, A.; Malagola, M.; Testoni, N.; Amabile, M.; Mazza, P.; Gobbi, M.; Zaccaria, A.; Lauria, F.; Fanin, R.; Visani, G.; Baccarani, M.
Fludarabine, Cytarabine (ARA-C) and Idarubicin (FLAI) versus Idarubucin ARA-C and Etoposide (ICE) for induction treatment of younger ,newly diagnosed acute myeloid leukemia patients: a multicentre phase III trial
2006-01-01 Martinelli, G.; Russo, D.; Malagola, M.; De VIVO, A.; Piccaluga, P. P.; Paolini, S.; Damiani, Daniela; Candoni, A.; Testoni, N.; Ottaviani, E.; Rondoni, M.; Mazza, P.; Zaccaria, A.; Lauria, F.; Avanzini, P.; Baccarani, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Dendritic cell recovery after allogeneic stem cell transplantation. | 1-gen-2002 | Stocchi, R.; Damiani, Daniela; Masolini, P.; Michelutti, A.; Geromin, A.; Sperotto, A.; Skert, C.; Tomadini, V.; Cerno, M.; Baccarani, M.; Fanin, R. | |
| Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection | 1-gen-2004 | Libra, M; DE RE, V; Gloghini, A; Gasparotto, D; Gragnani, L; Navolanic, Pm; DE VITA, Salvatore; Mazzarino, Mc; Zignego, Al; Carbone, A; Boiocchi, M. | |
| Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons. | 1-gen-1994 | Silvestri, F; Virgolini, L; Mazzolini, A; Bertolissi, F; Russo, D; Fanin, Renato; Baccarani, M. | |
| Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma. | 1-gen-2002 | Patriarca, Francesca; Sperotto, A; Filì, C; Zaja, Francesco; Prosdocimo, S; Fanin, Renato | |
| Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. | 1-gen-1997 | Michelutti, A; Michieli, M; Damiani, Daniela; Melli, C; Ermacora, A; Grimaz, S; Candoni, A; Russo, D; Fanin, Renato; Baccarani, M. | |
| Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation. | 1-gen-2006 | Patriarca, Francesca; Skert, C; Bonifazi, F; Sperotto, A; Fili, C; Stanzani, M; Zaja, Francesco; Cerno, M; Geromin, A; Bandini, G; Baccarani, M; Fanin, Renato | |
| Efficacy and toxycity of Fludarabin, Ara-C and Idarubicin vs Idarubucin, ARA-C and Etoposide for induction treatment of newly diagnosed acute myeloid leukemia patients, younger than 60 years. | 1-gen-2003 | Russo, D.; Martinelli, G.; Damiani, Daniela; Malagola, M.; Isidori, A.; De Vivo, A.; Visani, G.; Candoni, A.; Michelutti, A.; Fanin, R.; Piccaluga, P.; Bonini, A.; Avanzini, P.; Gugliottta, L.; Zuffa, E.; Zaccaria, A.; Raspadori, D.; Bocchia, M.; Lauria, F.; Pricolo, G.; Mazza, P.; Pierri, I.; Gobbi, M.; Baccarani, M. | |
| Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. | 1-gen-2005 | Patriarca, Francesca; Prosdocimo, S; Tomadini, V; Vasciaveo, A; Bruno, B; Fanin, Renato | |
| Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials | 1-gen-2021 | Gentile, M.; Specchia, G.; Derudas, D.; Galli, M.; Botta, C.; Rocco, S.; Conticello, C.; Califano, C.; Giuliani, N.; Mangiacavalli, S.; Attingenti, E.; Lombardo, A.; Brunori, M.; Rossi, E.; Antonioli, E.; Ria, R.; Zambello, R.; Di Renzo, N.; Mele, G.; Marcacci, G.; Musto, P.; Capalbo, S.; Cascavilla, N.; Cerchione, C.; Belotti, A.; Criscuolo, C.; Uccello, G.; Curci, P.; Vigna, E.; Fraticelli, V.; Vincelli, D.; Bonalumi, A.; Siniscalchi, A.; Stocchi, R.; Martino, M.; Ballanti, S.; Gangemi, D.; Gagliardi, A.; Gamberi, B.; Pompa, A.; Recchia, A. G.; Tripepi, G.; Pitino, A. | |
| “Expression of Multidrug resistance gene (MDR-1) in human normal leukocytes” | 1-gen-1993 | Damiani, Daniela; Michieli, M.; Michelutti, A.; Geromin, A.; Raspadori, D.; Fanin, Renato; Savignano, C.; Giacca, M.; Pileri, S.; Mallardi, F.; Baccarani, M. | |
| Factor V leiden increases plasma F1+2 levels both in normal and deep venous thrombosis subjects. | 1-gen-2000 | Mercuri, F; Giacomello, Roberta; Puglisi, Fabio; Colaone, R; Fabbro, D; Menegon, Mg; Ceriello, A; Gonano, Fabio; Damante, Giuseppe | |
| FEASIBILITY AND OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH POOR RISK ACUTE MYELOID LEUKEMIA | 1-gen-2009 | Candoni, A.; Simeone, E.; Sperotto, A.; Geromin, A.; Cerno, M.; Patriarca, Francesca; Zaja, Francesco; Damiani, Daniela; Fanin, R. | |
| FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS | 1-gen-2002 | Damiani, Daniela; Stocchi, R; Masolini, M; Sperotto, A; Geromin, A; Skert, C; Cerno, M; Baccarani, M; Fanin, Renato | |
| First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: A pooled analysis of two randomized trials | 1-gen-2020 | Larocca, A.; Mina, R.; Offidani, M.; Liberati, A. M.; Ledda, A.; Patriarca, F.; Evangelista, A.; Spada, S.; Benevolo, G.; Oddolo, D.; Innao, V.; Cangiolosi, C.; Bernardini, A.; Musto, P.; Amico, V.; Fraticelli, V.; Paris, L.; Giuliani, N.; Falcone, A. P.; Zambello, R.; de Paoli, L.; Romano, A.; Palumbo, A.; Montefusco, V.; Hajek, R.; Boccadoro, M.; Bringhen, S. | |
| FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) AS INDUCTION CHEMOTHERAPY OF ADULT ACUTE MYELOID LEUKEMIA. A PILOT STUDY REPORT | 1-gen-2009 | A., Candoni; E., Simeone; A., Michelutti; Damiani, Daniela; D., Russo; R., Fanin | |
| FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) INDUCTION CHEMOTHERAPY FOR ADULT ACUTE MYELOID LEUKEMIA. RESULTS OF A PILOT STUDY | 1-gen-2009 | Candoni, A.; Tiribelli, Mario; Simeone, E.; Volpetti, S.; Florio, F.; Malagola, M.; Damiani, Daniela; Russo, D.; Fanin, R. | |
| Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | 1-gen-2003 | Mauro, Fr; Zinzani, P; Zaja, Francesco; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, Renato; Baccarani, M; Tura, S; Mandelli, F. | |
| Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia. | 1-gen-1998 | Russo, D; Candoni, A; Grattoni, R; Bertone, A; Zaja, Francesco | |
| Fludarabine, Arabynosil cytosine and Idarubicin (FLAI), a combination of non MDR related drugs for tratment of patients with newly diagnosed acute myeloi leukemia. | 1-gen-2003 | Russo, D.; Damiani, Daniela; Martinelli, G.; Candoni, A.; Pricoli, G.; Pierri, I.; Zuffa, E.; Raspadori, D.; Bocchia, M.; Michelutti, A.; De Vivo, A.; Malagola, M.; Testoni, N.; Amabile, M.; Mazza, P.; Gobbi, M.; Zaccaria, A.; Lauria, F.; Fanin, R.; Visani, G.; Baccarani, M. | |
| Fludarabine, Cytarabine (ARA-C) and Idarubicin (FLAI) versus Idarubucin ARA-C and Etoposide (ICE) for induction treatment of younger ,newly diagnosed acute myeloid leukemia patients: a multicentre phase III trial | 1-gen-2006 | Martinelli, G.; Russo, D.; Malagola, M.; De VIVO, A.; Piccaluga, P. P.; Paolini, S.; Damiani, Daniela; Candoni, A.; Testoni, N.; Ottaviani, E.; Rondoni, M.; Mazza, P.; Zaccaria, A.; Lauria, F.; Avanzini, P.; Baccarani, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile